tiprankstipranks
Advertisement
Advertisement
Bio-Path Holdings Seeks Financing for Strategic Turnaround
PremiumCompany AnnouncementsBio-Path Holdings Seeks Financing for Strategic Turnaround
5M ago
BPTH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BPTH Upcoming Earnings Report: What to Expect?
5M ago
Bio-Path Holdings’ BP1001-A Study: A New Hope for Solid Tumor Treatment
Premium
Company Announcements
Bio-Path Holdings’ BP1001-A Study: A New Hope for Solid Tumor Treatment
5M ago
Bio-Path Holdings Faces Leadership Changes and Operational Pause
PremiumCompany AnnouncementsBio-Path Holdings Faces Leadership Changes and Operational Pause
9M ago
Bio-Path price target lowered to $2 from $9 at Roth Capital
Premium
The Fly
Bio-Path price target lowered to $2 from $9 at Roth Capital
10M ago
Bio-Path provides highlights from clinical, operational update
Premium
The Fly
Bio-Path provides highlights from clinical, operational update
10M ago
Bio-Path reports FY24 EPS ($4.12) vs ($33.63) last year
PremiumThe FlyBio-Path reports FY24 EPS ($4.12) vs ($33.63) last year
1y ago
Bio-Path Holdings Reports Promising Pre-Clinical Results
Premium
Company Announcements
Bio-Path Holdings Reports Promising Pre-Clinical Results
1y ago
Bio-Path reports results from preclinical studies of BP1001-A
Premium
The Fly
Bio-Path reports results from preclinical studies of BP1001-A
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100